by country – Page 19 – Retraction Watch

PLOS ONE realizes an academic editor had a conflict of interest that the publisher says it now tries harder to avoid

A group of genetics researchers in Italy has lost a 2014 paper in PLOS ONE for a range of image problems and a glaring conflict of interest.

The article, titled “Neuronal differentiation dictates estrogen-dependent survival and ERK1/2 kinetic by means of caveolin-1,” came from a team led by Luca Colucci-D’Amato, of the Second University of Naples.

The retraction notice in PLOS ONE lays out a raft of issues with the paper, for example:

No ‘possible fraudulent explanation’: Frequent co-author tasked with clearing colleagues of image manipulation

A journal has allowed a group of researchers in Italy to correct a 2016 paper with questionable images after a faculty member in their institution — and a frequent co-author of the group’s — said his investigation found no reason to doubt their integrity.

The article, “Arg tyrosine kinase modulates TGF-β1 production in human renal tubular cells under high-glucose conditions,” appeared in the Journal of Cell Science. Earlier this year, a poster on PubPeer pointed out “problematic similarities” with figures in the article.

The similarities evidently didn’t trouble Fulvio Magni, a professor of biochemistry at Milano-Bicocca who was tasked with investigating the case. Magni, we think we should note, has also been a co-author with members of the research group (see here, here, here and here, for a few examples).

According to the correction:

Former Northwestern psychology prof has paper subjected to an expression of concern

A paper by Ping Dong, a former researcher at Northwestern who left her post less than a year after having a paper retracted from Psychological Science, has been subjected to an expression of concern.

The 2017 paper, in the Journal of Consumer Research, claimed to show that “Witnessing Moral Violations Increases Conformity in Consumption.” It has been cited just twice, according to Clarivate Analytics’ Web of Knowledge.

The expression of concern reads:

A journal has its version of an NBA moment

Authors are calling “no traveling” on Liver Research for changing their affiliation without permission.

Editors at the publication changed the affiliation of a group of researchers from several institutions in Taiwan– including the Taipei Veterans General Hospital and the National Yang-Ming University School of Medicine, also in Taipei — to mainland China.

The notice for the article, “Do different bariatric surgery procedures impact hepassocin plasma levels in patients with type 2 diabetes mellitus?,” reads:

A researcher with 30 retractions and counting: The whistleblower speaks

Via U.S. SEC Office of the Whistleblower

Retraction Watch readers who have been following our coverage of retractions by Ali Nazari may have noticed that an anonymous whistleblower was the person who flagged the issues for journals and publishers. That whistleblower uses the pseudonym Artemisia Stricta, and we’re pleased to present a guest post written by him or her.

Something is seriously out of place with the roughly 200 publications by Ali Nazari, a scientist at Swinburne University who studies structural materials. Some of these problems have been known by journals and publishers for years — some since 2012 — yet their response has been mixed. Some have retracted papers. Some have decided not to, so far. And others have been mum.

In 2014, a study claimed high heels made women more attractive. Now it’s been retracted.

Perhaps you saw the headlines back in 2014, ones like “Science Proves It: Men Really Do Find High Heels Sexier,” from TIME.

Or maybe this quote, from the author of a study in Archives of Sexual Behavior, on CNBC:

Wanted: Lawyer to take case of Ohio cancer researcher with retraction-rich CV

Carlo Croce, the embattled and litigious cancer researcher at The Ohio State University, may be on the market for a new attorney.

Croce, who unsuccessfully sued the New York Times for libel after the newspaper reported on misconduct allegations against him, has been waging a second legal front against his institution. The grounds: Croce wants Ohio State to restore him to his position as chair of the Department of Cancer Biology and Genetics — a demand OSU has so far rejected.

Court documents suggest that the case has proceeded to depositions. But we’ve learned that Croce’s attorneys in the academic matter have dropped him as a client. In a motion approved earlier this month, the lawyers, from the Columbus firm James E. Arnold & Associates, petitioned to be removed from the case.

Fishy data doom paper by USDA aquaculture researcher

A scientist for the U.S. government has lost a 2017 paper on spawning in catfish for problems with the data.

The paper, “Effective dose of salmon GnRHa for induction of ovulation in channel catfish,” was written by Nagaraj G. Chatakondi and appeared in the North American Journal of Aquaculture. Chatakondi is a geneticist with the Stoneville, Miss., office of the Agricultural Research Service, a division of the U.S. Department of Agriculture.

According to the notice:

‘The problem is that there is no IL-26 gene in the mouse’ — an exasperated letter leads to a retraction

A group of ophthalmology researchers in China got caught trying to pull the wool over the eyes of readers by falsely claiming to have used a therapy that doesn’t exist.

As its title would indicate, the article, “Anti-angiogenic effect of Interleukin-26 in oxygen-induced retinopathy mice via inhibiting NFATc1-VEGF pathway,” by a team from Jinhua Municipal Central Hospital in Zhejiang, purported to show that IL-26 could prevent the growth of new blood vessels in mice with damaged retinas.

Per the abstract of the paper, which appeared in Biochemical and Biophysical Research Communications (BBRC):

“Highly unusual and unfortunate error” delays retraction two years in high-profile Duke case

As we’ve noted before, “the wheels of scientific publishing turn slowly … but they do (sometimes) turn.”

More than six years after the first retraction for Erin Potts-Kant, who was part of a group at Duke whose work would unravel amid misconduct allegations and lead to a $112.5 million settlement earlier this year with the U.S. government — and two years after a journal says it first became aware of the issues — a retraction by the group has appeared in Pediatric Research, a Springer Nature title.

Here’s the retraction notice for “Intra-amniotic LPS amplifies hyperoxia-induced airway hyperreactivity in neonatal rats”:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: